15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Pulse Biosciences Inc, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $43.00 to $58.00, so the covering firms are broadly aligned. The average target of $50.50 sits 4% above the current $48.76. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.29 next quarter toward $-1.16 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Strong Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Pulse Biosciences Inc.
As of Sep, 2 of 2 firms rate PLSE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
PLSE EPS & revenue forecast
EPS · NEXT QUARTER
$-0.29
Range $-0.30 – $-0.29 · 2 analysts · +64% YoY
Next period, 2 analysts expect Pulse Biosciences Inc to earn $-0.29 a share (range $-0.30 – $-0.29), versus $-0.18 a year earlier. Full-year consensus is $-1.10, growing to $-1.16 the year after.
REVENUE · NEXT QUARTER
$666.7K
Range $400.0K – $800.0K · 2 analysts · +153% YoY
Revenue is expected to reach $666.7K (range $400.0K – $800.0K), +152.5% year-over-year. Full-year consensus is $2.0M, rising to $7.9M next year.
Top analysts covering Pulse Biosciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PLSE.
#1
Anthony Petrone
Mizuho · Rank #86
Buy
$30.00-38.5% to target
Overall win rate
46%
+ Follow
#2
Mike Matson
Needham · Rank #210
Buy
$58.00+18.9% to target
Overall win rate
34%
+ Follow
#3
William Plovanic
Canaccord Genuity · Rank #243
Buy
$43.00-11.8% to target
Overall win rate
37%
+ Follow
#4
Suraj Kalia
Oppenheimer
Buy
$30.00-38.5% to target
Coverage
—
+ Follow
PLSE stock forecast FAQ
What is PLSE's average 12-month price target?+
The 2 analysts with a live target average $50.50 for Pulse Biosciences Inc over the next 12 months, ranging from a $58.00 high to a $43.00 low.
Is PLSE stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for PLSE?+
The Street-high target is $58.00 (Needham), and the Street-low is $43.00 (Canaccord Genuity). The average of all 2 active targets is $50.50.
How many Wall Street analysts cover PLSE?+
2 analysts have an active rating on Pulse Biosciences Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering PLSE?+
Among analysts who currently cover PLSE, Anthony Petrone of Mizuho has the strongest overall Quantellect track record (Rank #86). Their current call is Buy with a $30.00 target.
What is Pulse Biosciences Inc's projected EPS for next quarter?+
The consensus estimate is $-0.29 per share (range $-0.30 – $-0.29) across 2 analysts. Full-year EPS is projected at $-1.10, rising to $-1.16 the following year.
How much revenue is Pulse Biosciences Inc expected to report next quarter?+
Consensus revenue is $666.7K (range $400.0K – $800.0K). Full-year revenue is projected at $2.0M, growing to $7.9M next year.
Have analysts been upgrading or downgrading PLSE lately?+
As of Sep, 2 of 2 firms rate PLSE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PLSE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
